EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 -0.0258
March 31, 2026 -0.0175
December 31, 2025 -0.0072
September 30, 2025 -0.0127
June 30, 2025 -0.056
March 31, 2025 -0.0261
December 31, 2024 -0.4806
September 30, 2024 -0.0954
June 30, 2024 -0.0478
March 31, 2024 -0.0616
December 31, 2023 -0.0899
September 30, 2023 0.0011
June 30, 2023 -0.0745
March 31, 2023 -0.1202
December 31, 2022 -0.1938
September 30, 2022 -0.1308
June 30, 2022 -0.2258
March 31, 2022 -0.165
December 31, 2021 -0.099
September 30, 2021 -0.2672
June 30, 2021 -0.2535
March 31, 2021 -0.2339
December 31, 2020 -0.0793
September 30, 2020 -0.0979
June 30, 2020 -0.075
Date Value
March 31, 2020 -0.0785
December 31, 2019 -0.0843
September 30, 2019 -0.0694
June 30, 2019 -0.068
March 31, 2019 -0.1082
December 31, 2018 -0.0743
September 30, 2018 -0.1066
June 30, 2018 -0.067
March 31, 2018 -0.0615
December 31, 2017 -0.0454
September 30, 2017 -0.1214
June 30, 2017 -0.0949
March 31, 2017 -0.184
December 31, 2016 -0.1232
September 30, 2016 -0.1386
June 30, 2016 -0.2381
March 31, 2016 -0.1889
December 31, 2015 -0.1654
September 30, 2015 -0.1401
June 30, 2015 -0.1709
March 31, 2015 -0.1385
December 31, 2014 -0.0454
September 30, 2014 -0.2591
June 30, 2014 -0.1364
March 31, 2014 -0.1158

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 0.0141
Healios KK 0.0554
GNI Group Ltd. 0.0156
Agenus, Inc. -0.0146
Amgen, Inc. 4.366